Orange Book product · Generic (ANDA)
NAFCILLIN SODIUM
NAFCILLIN SODIUM
At a glance
Dec 26, 2012
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 26, 2012
13 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
NAFCILLIN SODIUM
Strength
EQ 1GM BASE/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 091613
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of NAFCILLIN SODIUM
- 1989NALLPEN IN PLASTIC CONTAINERBrand (NDA)
NDA 050655 · BAXTER HLTHCARE
- —UNIPENBrand (NDA)
NDA 050111 · WYETH AYERST
- —UNIPENBrand (NDA)
NDA 050199 · WYETH AYERST
- —UNIPENBrand (NDA)
NDA 050320 · WYETH AYERST
- —UNIPENBrand (NDA)
NDA 050462 · WYETH AYERST
- 2020NAFCILLIN SODIUMGeneric (ANDA)
ANDA 206761 · FRESENIUS
- 2019NAFCILLIN SODIUMGeneric (ANDA)
ANDA 206682 · FRESENIUS
- 2014NAFCILLIN SODIUMGeneric (ANDA)
ANDA 200002 · ONESOURCE SPECIALTY
- 2012NAFCILLIN SODIUMGeneric (ANDA)
ANDA 091614 · EUGIA PHARMA SPECLTS
- 2012NAFCILLIN SODIUMGeneric (ANDA)
ANDA 090582 · SAGENT PHARMS
- 2012NAFCILLIN SODIUMGeneric (ANDA)
ANDA 090580 · SAGENT PHARMS
- 2011NAFCILLIN SODIUMGeneric (ANDA)
ANDA 090560 · ANTIBIOTICE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
